APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lumateperone

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Lumateperone Market Outlook and Growth Opportunities 2026

30 December 2025196 pages

Choose your research edition.

Industry ResearchLumateperone Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Lumateperone Industry Growth and Trends Forecast to 203272 pages · $3,450 USDMarket StructureGlobal Lumateperone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lumateperone Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Lumateperone Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Lumateperone market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Lumateperone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Lumateperone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lumateperone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Lumateperone market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Lumateperone market include Intra‑Cellular Therapies. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Lumateperone market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lumateperone and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lumateperone sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Lumateperone market size, projected growth trends, production technologies, key applications, and end-use industries.

Lumateperone Segment by Company

Intra‑Cellular Therapies

Lumateperone Segment by Type

Capsules

Injectable

Lumateperone Segment by Application

Schizophrenia

Depression

Other

Lumateperone Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Lumateperone status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Lumateperone market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Lumateperone significant trends, drivers, influence factors in global and regions.

6. To analyze Lumateperone competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lumateperone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lumateperone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lumateperone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Lumateperone market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Lumateperone industry.

Chapter 3: Detailed analysis of Lumateperone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Lumateperone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Lumateperone in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Lumateperone Industry Trends Table 2. Lumateperone Industry Drivers Table 3. Lumateperone Industry Opportunities and Challenges Table 4. Lumateperone Industry Restraints Table 5. Global Lumateperone Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Lumateperone Revenue Share by Company (2021-2026) Table 7. Global Lumateperone Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Lumateperone Sales Volume Share by Company (2021-2026) Table 9. Global Lumateperone Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Lumateperone Company Ranking, (2024-2026) & (USD Million) Table 11. Global Lumateperone Key Company Manufacturing Base & Headquarters Table 12. Global Lumateperone Company, Product Type & Application Table 13. Global Lumateperone Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Lumateperone by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Capsules Table 18. Significant Companies of Injectable Table 19. Global Lumateperone Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Lumateperone Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Lumateperone Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Lumateperone Sales Volume Share by Type (2021-2026) Table 23. Global Lumateperone Sales Volume Share by Type (2027-2032) Table 24. Global Lumateperone Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Lumateperone Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Lumateperone Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Lumateperone Sales Value Share by Type (2021-2026) Table 28. Global Lumateperone Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Schizophrenia Table 30. Significant Companies of Depression Table 31. Significant Companies of Other Table 32. Global Lumateperone Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Lumateperone Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Lumateperone Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Lumateperone Sales Volume Share by Application (2021-2026) Table 36. Global Lumateperone Sales Volume Share by Application (2027-2032) Table 37. Global Lumateperone Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Lumateperone Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Lumateperone Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Lumateperone Sales Value Share by Application (2021-2026) Table 41. Global Lumateperone Sales Value Share by Application (2027-2032) Table 42. Global Lumateperone Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Lumateperone Sales by Region (2021-2026) & (K Units) Table 44. Global Lumateperone Sales Market Share by Region (2021-2026) Table 45. Global Lumateperone Sales by Region (2027-2032) & (K Units) Table 46. Global Lumateperone Sales Market Share by Region (2027-2032) Table 47. Global Lumateperone Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Lumateperone Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Lumateperone Sales Value Share by Region (2021-2026) Table 50. Global Lumateperone Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Lumateperone Sales Value Share by Region (2027-2032) Table 52. Global Lumateperone Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Lumateperone Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Lumateperone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Lumateperone Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Lumateperone Sales by Country (2021-2026) & (K Units) Table 57. Global Lumateperone Sales Market Share by Country (2021-2026) Table 58. Global Lumateperone Sales by Country (2027-2032) & (K Units) Table 59. Global Lumateperone Sales Market Share by Country (2027-2032) Table 60. Global Lumateperone Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Lumateperone Sales Value Market Share by Country (2021-2026) Table 62. Global Lumateperone Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Lumateperone Sales Value Market Share by Country (2027-2032) Table 64. Intra‑Cellular Therapies Company Information Table 65. Intra‑Cellular Therapies Business Overview Table 66. Intra‑Cellular Therapies Lumateperone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Intra‑Cellular Therapies Lumateperone Product Portfolio Table 68. Intra‑Cellular Therapies Recent Development Table 69. Key Raw Materials Table 70. Raw Materials Key Suppliers Table 71. Lumateperone Distributors List Table 72. Lumateperone Customers List Table 73. Research Programs/Design for This Report Table 74. Authors List of This Report Table 75. Secondary Sources Table 76. Primary Sources List of Figures Figure 1. Lumateperone Product Image Figure 2. Global Lumateperone Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lumateperone Sales Value (2021-2032) & (US$ Million) Figure 4. Global Lumateperone Sales (2021-2032) & (K Units) Figure 5. Global Lumateperone Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Lumateperone Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Capsules Image Figure 10. Injectable Image Figure 11. Global Lumateperone Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Lumateperone Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Lumateperone Sales Volume Share by Type (2021-2032) Figure 14. Global Lumateperone Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Lumateperone Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Lumateperone Sales Value Share by Type (2021-2032) Figure 17. Schizophrenia Image Figure 18. Depression Image Figure 19. Other Image Figure 20. Global Lumateperone Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Lumateperone Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Lumateperone Sales Volume Share by Application (2021-2032) Figure 23. Global Lumateperone Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Lumateperone Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Lumateperone Sales Value Share by Application (2021-2032) Figure 26. Global Lumateperone Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Lumateperone Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Lumateperone Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Lumateperone Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Lumateperone Sales Value (2021-2032) & (US$ Million) Figure 31. North America Lumateperone Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Lumateperone Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Lumateperone Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Lumateperone Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Lumateperone Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Lumateperone Sales Value (2021-2032) & (US$ Million) Figure 37. South America Lumateperone Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Lumateperone Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Lumateperone Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Lumateperone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Lumateperone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Lumateperone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Lumateperone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Lumateperone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Lumateperone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Lumateperone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Lumateperone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Lumateperone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Lumateperone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Lumateperone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Lumateperone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Lumateperone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Lumateperone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Lumateperone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Lumateperone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Lumateperone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Lumateperone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Lumateperone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Lumateperone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Lumateperone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Lumateperone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Lumateperone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Lumateperone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Lumateperone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Lumateperone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Lumateperone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Lumateperone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Lumateperone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Lumateperone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Lumateperone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Lumateperone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Lumateperone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Lumateperone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Lumateperone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Lumateperone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Lumateperone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Lumateperone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Lumateperone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Lumateperone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Lumateperone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Lumateperone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Lumateperone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Lumateperone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Lumateperone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Lumateperone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Lumateperone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Lumateperone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Lumateperone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Lumateperone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Lumateperone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Lumateperone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Lumateperone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Lumateperone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Lumateperone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Lumateperone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Lumateperone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Lumateperone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Lumateperone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Lumateperone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Lumateperone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Lumateperone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Lumateperone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Lumateperone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Lumateperone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Lumateperone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Lumateperone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Lumateperone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Lumateperone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Lumateperone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Lumateperone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Lumateperone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Lumateperone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Lumateperone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Lumateperone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Lumateperone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Lumateperone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Lumateperone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Lumateperone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Lumateperone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Lumateperone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Lumateperone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Lumateperone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Lumateperone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Lumateperone Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Lumateperone Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Capsules
  • Injectable
Applications
  • Schizophrenia
  • Depression
  • Other
Companies covered
  • Intra‑Cellular Therapies

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Lumateperone Sales Value (2021-2032)
  4. 1.2.2 Global Lumateperone Sales Volume (2021-2032)
  5. 1.2.3 Global Lumateperone Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Lumateperone Market Dynamics
  1. 2.1 Lumateperone Industry Trends
  2. 2.2 Lumateperone Industry Drivers
  3. 2.3 Lumateperone Industry Opportunities and Challenges
  4. 2.4 Lumateperone Industry Restraints
3 Lumateperone Market by Company
  1. 3.1 Global Lumateperone Company Revenue Ranking in 2025
  2. 3.2 Global Lumateperone Revenue by Company (2021-2026)
  3. 3.3 Global Lumateperone Sales Volume by Company (2021-2026)
  4. 3.4 Global Lumateperone Average Price by Company (2021-2026)
  5. 3.5 Global Lumateperone Company Ranking (2024-2026)
  6. 3.6 Global Lumateperone Company Manufacturing Base and Headquarters
  7. 3.7 Global Lumateperone Company Product Type and Application
  8. 3.8 Global Lumateperone Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Lumateperone Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Lumateperone Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Lumateperone Market by Type
  1. 4.1 Lumateperone Type Introduction
  2. 4.1.1 Capsules
  3. 4.1.2 Injectable
  4. 4.2 Global Lumateperone Sales Volume by Type
  5. 4.2.1 Global Lumateperone Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Lumateperone Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Lumateperone Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Lumateperone Sales Value by Type
  9. 4.3.1 Global Lumateperone Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Lumateperone Sales Value by Type (2021-2032)
  11. 4.3.3 Global Lumateperone Sales Value Share by Type (2021-2032)
5 Lumateperone Market by Application
  1. 5.1 Lumateperone Application Introduction
  2. 5.1.1 Schizophrenia
  3. 5.1.2 Depression
  4. 5.1.3 Other
  5. 5.2 Global Lumateperone Sales Volume by Application
  6. 5.2.1 Global Lumateperone Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Lumateperone Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Lumateperone Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Lumateperone Sales Value by Application
  10. 5.3.1 Global Lumateperone Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Lumateperone Sales Value by Application (2021-2032)
  12. 5.3.3 Global Lumateperone Sales Value Share by Application (2021-2032)
6 Lumateperone Regional Sales and Value Analysis
  1. 6.1 Global Lumateperone Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Lumateperone Sales by Region (2021-2032)
  3. 6.2.1 Global Lumateperone Sales by Region: 2021-2026
  4. 6.2.2 Global Lumateperone Sales by Region (2027-2032)
  5. 6.3 Global Lumateperone Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Lumateperone Sales Value by Region (2021-2032)
  7. 6.4.1 Global Lumateperone Sales Value by Region: 2021-2026
  8. 6.4.2 Global Lumateperone Sales Value by Region (2027-2032)
  9. 6.5 Global Lumateperone Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Lumateperone Sales Value (2021-2032)
  12. 6.6.2 North America Lumateperone Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Lumateperone Sales Value (2021-2032)
  15. 6.7.2 Europe Lumateperone Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Lumateperone Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Lumateperone Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Lumateperone Sales Value (2021-2032)
  21. 6.9.2 South America Lumateperone Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Lumateperone Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Lumateperone Sales Value Share by Country, 2025 VS 2032
7 Lumateperone Country-level Sales and Value Analysis
  1. 7.1 Global Lumateperone Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Lumateperone Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Lumateperone Sales by Country (2021-2032)
  4. 7.3.1 Global Lumateperone Sales by Country (2021-2026)
  5. 7.3.2 Global Lumateperone Sales by Country (2027-2032)
  6. 7.4 Global Lumateperone Sales Value by Country (2021-2032)
  7. 7.4.1 Global Lumateperone Sales Value by Country (2021-2026)
  8. 7.4.2 Global Lumateperone Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Lumateperone Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Lumateperone Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Lumateperone Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Lumateperone Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Lumateperone Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Lumateperone Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Lumateperone Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Lumateperone Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Lumateperone Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Lumateperone Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Lumateperone Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Lumateperone Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Lumateperone Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Lumateperone Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Lumateperone Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Lumateperone Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Lumateperone Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Lumateperone Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Lumateperone Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Lumateperone Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Lumateperone Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Lumateperone Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Lumateperone Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Lumateperone Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Lumateperone Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Lumateperone Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Lumateperone Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Lumateperone Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Lumateperone Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Lumateperone Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Lumateperone Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Lumateperone Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Lumateperone Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Lumateperone Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Lumateperone Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Lumateperone Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Lumateperone Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Lumateperone Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Lumateperone Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Lumateperone Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Lumateperone Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Lumateperone Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Lumateperone Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Lumateperone Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Lumateperone Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Lumateperone Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Lumateperone Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Lumateperone Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Lumateperone Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Lumateperone Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Lumateperone Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Lumateperone Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Lumateperone Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Lumateperone Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Lumateperone Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Lumateperone Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Lumateperone Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Lumateperone Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Lumateperone Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Lumateperone Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Lumateperone Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Lumateperone Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Lumateperone Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Lumateperone Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Lumateperone Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Lumateperone Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Lumateperone Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Lumateperone Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Lumateperone Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Lumateperone Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Lumateperone Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Lumateperone Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Lumateperone Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Lumateperone Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Lumateperone Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Lumateperone Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Lumateperone Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Lumateperone Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Lumateperone Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Lumateperone Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Lumateperone Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Lumateperone Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Lumateperone Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Lumateperone Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Intra‑Cellular Therapies
  2. 8.1.1 Intra‑Cellular Therapies Company Information
  3. 8.1.2 Intra‑Cellular Therapies Business Overview
  4. 8.1.3 Intra‑Cellular Therapies Lumateperone Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Intra‑Cellular Therapies Lumateperone Product Portfolio
  6. 8.1.5 Intra‑Cellular Therapies Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Lumateperone Value Chain Analysis
  2. 9.1.1 Lumateperone Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Lumateperone Sales Mode & Process
  6. 9.2 Lumateperone Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Lumateperone Distributors
  9. 9.2.3 Lumateperone Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst